We are pleased to announce that the Danish venture capital company Sunstone Capital A/S has invested in our company. Biomonitor A/S is with this investment ready to go after the $ 800M theranostics market for screening for antibodies against biopharmaceuticals.

Please download the press release for details.

For further information please contact:
Arsalan Kharazmi, CEO, Biomonitor A/S.  E-mail: ak @ biomon.dk, Phone: +45 39179797
Søren Lemonius, Partner, Sunstone Capital A/S,  E-mail: Lemonius @ sunstonecapital.com, Phone: +45 40814889